208 related articles for article (PubMed ID: 16078921)
21. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004.
O'Leary DR; Kuhn S; Kniss KL; Hinckley AF; Rasmussen SA; Pape WJ; Kightlinger LK; Beecham BD; Miller TK; Neitzel DF; Michaels SR; Campbell GL; Lanciotti RS; Hayes EB
Pediatrics; 2006 Mar; 117(3):e537-45. PubMed ID: 16510632
[TBL] [Abstract][Full Text] [Related]
22. Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry.
Larsen R; Berkowicz A; Lousen T; Hedegaard M; Clausen FB; Krog GR; Dziegiel MH
Transfusion; 2008 Aug; 48(8):1707-12. PubMed ID: 18482192
[TBL] [Abstract][Full Text] [Related]
23. Novel molecular basis of an Inab phenotype.
Hue-Roye K; Powell VI; Patel G; Lane D; Maguire M; Chung A; Reid ME
Immunohematology; 2005; 21(2):53-5. PubMed ID: 15954804
[TBL] [Abstract][Full Text] [Related]
24. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
25. Hemolytic transfusion reaction due to anti-Tc(a).
Kowalski MA; Pierce SR; Edwards RL; Ethirajan S; Ryan K; Livergood MP
Transfusion; 1999 Sep; 39(9):948-50. PubMed ID: 10533820
[TBL] [Abstract][Full Text] [Related]
26. Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.
Telen MJ; Rao N; Udani M; Thompson ES; Kaufman RM; Lublin DM
Blood; 1994 Nov; 84(9):3205-11. PubMed ID: 7524769
[TBL] [Abstract][Full Text] [Related]
27. A case of hemolytic disease of the newborn caused by anti-M: serological study of maternal blood.
Matsumoto H; Tamaki Y; Sato S; Shibata K
Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):525-8. PubMed ID: 7195138
[TBL] [Abstract][Full Text] [Related]
28. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.
Telen MJ; Hall SE; Green AM; Moulds JJ; Rosse WF
J Exp Med; 1988 Jun; 167(6):1993-8. PubMed ID: 2455016
[TBL] [Abstract][Full Text] [Related]
29. Example of a woman with multiple intrauterine deaths due to anti-M who delivered a live child after plasmapheresis.
Furukawa K; Nakajima T; Kogure T; Yazaki K; Yoshida M; Fukaishi T; Ibuki Y; Igarashi M
Exp Clin Immunogenet; 1993; 10(3):161-7. PubMed ID: 8286126
[TBL] [Abstract][Full Text] [Related]
30. Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibition.
Blackall DP; Pesek GD; Montgomery MM; Oza KK; Arndt PA; Garratty G; Shahcheraghi A; Denomme GA
Am J Perinatol; 2008 Oct; 25(9):541-5. PubMed ID: 18720327
[TBL] [Abstract][Full Text] [Related]
31. Management of anti-Jka alloimmunization.
Franco A; Rossi K; Krugh D; O'Shaughnessy R
J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
[TBL] [Abstract][Full Text] [Related]
32. Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin.
Palmeira P; Costa-Carvalho BT; Arslanian C; Pontes GN; Nagao AT; Carneiro-Sampaio MM
Pediatr Allergy Immunol; 2009 Sep; 20(6):528-35. PubMed ID: 19220771
[TBL] [Abstract][Full Text] [Related]
33. SERF: a new antigen in the Cromer blood group system.
Banks J; Poole J; Ahrens N; Seltsam A; Salama A; Hue-Roye K; Storry JR; Palacajornsuk P; Ma BW; Lublin DM; Reid ME
Transfus Med; 2004 Aug; 14(4):313-8. PubMed ID: 15285728
[TBL] [Abstract][Full Text] [Related]
34. Fetal hemolytic anemia and intrauterine death caused by anti-M immunization.
Wikman A; Edner A; Gryfelt G; Jonsson B; Henter JI
Transfusion; 2007 May; 47(5):911-7. PubMed ID: 17465958
[TBL] [Abstract][Full Text] [Related]
35. Circulating calcitonin gene-related peptide and its placental origins in normotensive and preeclamptic pregnancies.
Dong YL; Chauhan M; Green KE; Vegiraju S; Wang HQ; Hankins GD; Yallampalli C
Am J Obstet Gynecol; 2006 Dec; 195(6):1657-67. PubMed ID: 16996466
[TBL] [Abstract][Full Text] [Related]
36. The Cromer blood group system: a review.
Storry JR; Reid ME
Immunohematology; 2002; 18(4):95-103. PubMed ID: 15373545
[TBL] [Abstract][Full Text] [Related]
37. 3D analysis of CROMER (DAF) and a new antigen CRAG.
Floch A; Vege S; Hue-Roye K; Hamilton JR; Williams LA; Choate J; Lomas-Francis C; Westhoff CM
Blood Transfus; 2022 Nov; 20(6):483-488. PubMed ID: 35175190
[TBL] [Abstract][Full Text] [Related]
38. The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetes mellitus and nondiabetic controls.
Madazli R; Tuten A; Calay Z; Uzun H; Uludag S; Ocak V
Gynecol Obstet Invest; 2008; 65(4):227-32. PubMed ID: 18196904
[TBL] [Abstract][Full Text] [Related]
39. Anti-Ata causing mild hemolytic disease of the newborn.
Culver PL; Brubaker DB; Sheldon RE; Martin M; Richter CA
Transfusion; 1987; 27(6):468-70. PubMed ID: 3686655
[TBL] [Abstract][Full Text] [Related]
40. Severe hemolytic disease of the newborn due to anti-Cw.
Byers BD; Gordon MC; Higby K
Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1180-2. PubMed ID: 16260563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
